MedTech News
New period product offers progress in women’s health
Bryan Hsu is tackling an area of research that has long been neglected—menstrual products.
Cinnamon Adsorbent Dressings: Cinesteam®’s Natural-Based Solution for Chronic Wound Odor Management
FORT LAUDERDALE, Fla., July 10, 2024 /PRNewswire/ — Wounds can create malodorous smells in various settings and for a variety of reasons. For example, wound malodor can develop due to several healthcare conditions, including the treatment of tumoral wounds, pressure ulcers and sores, diabetic foot, burns, and post-surgery wounds
FDA clears ImmersiveTouch augmented reality surgical system
ImmersiveTouch announced today that it received FDA 510(k) clearance for its ImmersiveAR augmented reality technology platform.
Forma Medical Granted FDA Clearance For Optimal Plating System Enabling a Multi-Faceted Growth Strategy for MIS Forefoot Portfolio
CAMP HILL, Pa.–(BUSINESS WIRE)–Forma Medical Inc., a leading innovator in medical device technologies, is thrilled to announce the FDA 510(k) clearance for its groundbreaking OptimalMTP® Plating System. This regulatory milestone marks a significant leap forward in MIS (Minimally Invasive Surgery), ushering in a new era of precision and efficiency dedicated to foot and ankle surgery, one of the fastest growing segments in the medical device space.
Implantable LED device uses light to treat deep-seated cancers
To bring light’s benefits to these harder-to-access cancers, engineers and scientists at the University of Notre Dame have devised a wireless LED device that can be implanted. This device, when combined with a light-sensitive dye, not only destroys cancer cells, but also mobilizes the immune system’s cancer-targeting response.
Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution
Roche has announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made available to people living with type 1 and type 2 diabetes over the age of 18 on flexible insulin therapy.
FDA clears Orthofix Fitbone transport and lengthening system
Orthofix (Nasdaq: OFIX) today announced it received FDA 510(k) clearance for the Fitbone Transport and Lengthening System and reported the first implant of the device.
Cordis wins FDA nod for vascular closure device
Cordis announced today that the FDA granted premarket approval (PMA) for its Mynx Control venous vascular closure device (VCD).